Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Care Delivery Models Guide Cancer Practice During COVID-19
    COVID-19
    Care Delivery Models Guide Cancer Practice During COVID-19
    July 10, 2020
    Don’t Let Barriers Prevent You From Continuing Your Nursing Education
    Nurse empowerment
    Don’t Let Barriers Prevent You From Continuing Your Nursing Education
    July 03, 2020
    Nurses Have a Role and Responsibility in Ending Racism
    Patient advocacy
    Nurses Have a Role and Responsibility in Ending Racism
    June 26, 2020
    Oncology Nurses Have a Special Power of Presence
    Oncology nurse-patient relationship
    Oncology Nurses Have a Special Power of Presence
    June 19, 2020
    Virtual Care for Patients With Cancer in New Jersey During COVID-19
    COVID-19
    Virtual Care for Patients With Cancer in New Jersey During COVID-19
    June 08, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time
    Cancer research

    Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time

    More than 96% of participants in prostate cancer clinical trials are non-Hispanic white men even though non-Hispanic black men represent 22% of prostate cancer diagnoses, researchers reported in Cancer Epidemiology, Biomarkers, and Prevention. Even more critical, enrollment rates of black or African American men have been declining since 1995.

    July 08, 2020
    Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment
    Cancer research

    Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment

    A new class of drugs, antibody-drug conjugates (ADCs), combines the specificity of targeted therapy with the cytotoxicity of chemotherapy for a powerhouse effect against certain types of cancer variants. Here’s what you need to know about this novel treatment modality.

    July 01, 2020
    Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization
    Chemotherapy

    Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization

    Patients who take five or more medications in the six months before beginning IV chemotherapy for a cancer diagnosis are more likely to be hospitalized after their chemotherapy treatment, according to the findings from a new study published in the Journal of Geriatric Oncology.

    June 19, 2020
    Exercise Before ADT Treatment Reduces Rate of Side Effects
    Cancer research

    Exercise Before ADT Treatment Reduces Rate of Side Effects

    Beginning a supervised exercise program before the start of androgen deprivation therapy (ADT) for prostate cancer reduced the incidence of treatment-related side effects, researchers reported in a study published in BJU International.

    June 17, 2020
    Pelvic Radiation May Decrease Bone Mineral Density
    Radiation therapy

    Pelvic Radiation May Decrease Bone Mineral Density

    Women receiving pelvic radiation therapy for gynecologic cancers are at higher risk for significant decreases in bone mineral density (BMD), with 7.8% of women in the study diagnosed with a pelvic fracture, according to findings from a study published in Cancer.

    June 10, 2020
    Manage Late Effects From HPV-Positive Oropharyngeal Cancers
    Late effects

    Manage Late Effects From HPV-Positive Oropharyngeal Cancers

    The demographic of patients with oropharyngeal cancers is changing. Clinicians are diagnosing fewer older patients with a long history of heavy smoking and alcohol use; instead, a majority of patients are middle-aged Caucasian men who haven’t smoked but have had multiple sexual partners—and have tested positive for human papillomavirus.

    June 09, 2020
    E-Cigarettes Linked to Bladder Cancer Carcinogens
    Cancer research

    E-Cigarettes Linked to Bladder Cancer Carcinogens

    People who use e-cigarettes have six substances that have a strong link to bladder cancer in their urine, researchers reported in European Urology Oncology.

    June 03, 2020
    Proton Therapy May Reduce Radiation’s Severe Side Effects
    Radiation therapy

    Proton Therapy May Reduce Radiation’s Severe Side Effects

    Proton beam radiation therapy is safer and equally effective as traditional radiation for adults with advanced cancers, researchers reported in study findings in JAMA Oncology.

    May 27, 2020
    Innovative Clinics Help Patients Safely Access Cancer Care During COVID-19
    COVID-19

    Innovative Clinics Help Patients Safely Access Cancer Care During COVID-19

    No longer just a convenience, drive-throughs are an essential part of social distancing during the COVID-19 coronavirus pandemic. Retailers and healthcare providers alike have taken it beyond the typical food, prescriptions, and banking, offering everything from merchandise to virus testing—and now, thanks to the innovation of two oncology nurses, cancer care.

    May 20, 2020
    Investigational Maintenance Therapy Extends Survival in AML
    Cancer treatments

    Investigational Maintenance Therapy Extends Survival in AML

    A new drug is extending both remission and survival in adults with acute myeloid leukemia (AML), according to findings reported at the American Society of Hematology annual meeting in December 2019. The study was funded by Celgene, the drug’s manufacturer.

    May 20, 2020
    Dietary Supplements May Affect Breast Cancer Chemo Outcomes
    Chemotherapy

    Dietary Supplements May Affect Breast Cancer Chemo Outcomes

    Antioxidant supplements are associated with increased disease recurrence and statistically nonsignificant increased risk of mortality in patients with breast cancer who were receiving cyclophosphamide, doxorubicin, and paclitaxel, according to findings from a study reported in the Journal of Clinical Oncology.

    May 13, 2020
    How to Prevent Opioid Misuse While Effectively Managing Cancer Pain
    Pain management

    How to Prevent Opioid Misuse While Effectively Managing Cancer Pain

    Opioid misuse is prevalent among the U.S. population—so much so that President Trump declared it a public health emergency in 2017. At the same time, research shows that 20%–50% of patients with cancer and 80% of those with advanced-stage disease report experiencing moderate to severe pain. Balancing the dichotomies is difficult, but oncology nurses and other cancer care providers have a responsibility to provide comprehensive pain management for patients with cancer.

    May 12, 2020
    Remodeled CAR T-Cell Therapy May Reduce Side Effects
    Cancer treatments

    Remodeled CAR T-Cell Therapy May Reduce Side Effects

    A new type of remodeled CAR T-cell treatment is just as effective as the original therapy but may result in fewer neurologic side effects, researchers reported in Nature Medicine.

    May 06, 2020
    Drug Combo May Be Effective for BRCA-Mutated Pancreatic Cancer
    Pancreatic cancer

    Drug Combo May Be Effective for BRCA-Mutated Pancreatic Cancer

    More than 65% of patients with germline BRCA/PALB2-mutated pancreatic ductal adenocarcinoma responded to treatment with combination cisplatin and gemcitabine, according to results of a study reported in the Journal of Clinical Oncology. Two- and three-year survival rates reached 31% and 18%, respectively.  

    April 22, 2020
    Roadmap Helps Institutions Safely Resume Elective Surgeries After COVID-19
    COVID-19

    Roadmap Helps Institutions Safely Resume Elective Surgeries During COVID-19

    As the United States rolls out a plan to reopen the country’s nonessential businesses and services safely, hospitals and healthcare facilities are also developing strategies to resume elective surgeries. To help facilities guide their readiness assessment, prioritization, and scheduling, on April 17, 2020, the American College of Surgeons, American Society of Anesthesiologists, Association of Perioperative Registered Nurses, and American Hospital Association released a joint statement roadmap for elective surgeries following the COVID-19 pandemic.

    April 17, 2020
    New Treatments Show Promise for Metastatic HER2-Positive Breast Cancer
    Breast cancer

    New Treatments Show Promise for Metastatic HER2-Positive Breast Cancer

    Two new drugs in clinical trials are extending survival for women with metastatic HER2-positive breast cancer that had progressed with previous treatment. One of the drugs was effective for brain metastasis, which is particularly difficult to treat. Results from both studies were reported in the New England Journal of Medicine. 

    April 15, 2020
    Global Cancer Cases Could Increase 60% in Next 20 Years
    Cancer prevention

    Global Cancer Cases Could Increase 60% in Next 20 Years

    If current trends continue, the world will see a 60% increase in cancer diagnoses through 2040, the World Health Organization said in its February 2020 Report on Cancer: Setting Priorities, Investing Wisely, and Providing Care for All.  

    April 08, 2020
    Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says
    Nurse staffing

    Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says

    The world needs to invest in nursing education, jobs, and leadership if it intends to prevent the projected global shortage of nurses by 2030, the World Health Organization (WHO) said on April 6, 2020, in its State of the World’s Nursing 2020 report, a first-of-its kind look at nurses’ critical role in international health care.

    April 07, 2020
    Prevent, Recognize, and Manage Sepsis in Patients With Cancer
    Cancer prevention

    Prevent, Recognize, and Manage Sepsis in Patients With Cancer

    Because of weakened immune systems and prolonged treatment courses, patients with cancer have a higher chance of developing sepsis. Once acquired, sepsis puts patients at risk for hospitalization and increased morbidity and mortality. Prevention and prompt management are essential to improve outcomes. 

    April 07, 2020
    Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk
    Breast cancer

    Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk

    The Adjuvant Radiotherapy Intensification Classifier (ARTIC) predicts which women with early-stage breast cancer will benefit the most from radiotherapy, as well as their risk for locoregional recurrence after radiation, researchers reported in study findings published in the Journal of Clinical Oncology. 

    March 30, 2020
    Prostate Cancer Disparities Disappear With Equal Access to Care
    Cancer health disparities

    Prostate Cancer Disparities Disappear With Equal Access to Care

    Typically, African American men have worse outcomes from prostate cancer than their white counterparts. But according to the results of a new study in patients in the U.S. Department of Veterans Affairs (VA) health system where all patients have equal access to care, no disparities exist between the two groups—in fact, the African American men in the VA system had better outcomes than non-Hispanic whites. The findings were reported in Cancer.  

    March 27, 2020
    Pembrolizumab Is More Cost Effective Than Atezolizumab for NSCLC
    Oncology drug research

    Pembrolizumab Is More Cost Effective Than Atezolizumab for NSCLC

    Adding atezolizumab to treatment with bevacizumab, carboplatin, and paclitaxel as first-line therapy for metastatic, nonsquamous non-small cell lung cancer (NSCLC) is associated with survival benefit—but it comes at a cost, researchers said in study results published in JAMA Network Open. In comparison, pembrolizumab offers a more cost-effective survival benefit. 

    March 25, 2020
    Radiation Unnecessary for Children With ALL
    Radiation therapy

    Radiation Unnecessary for Children With ALL

    Children with acute lymphoblastic leukemia (ALL) at risk for cancer recurrence in the brain don’t need prophylactic radiation therapy, researchers reported in the Journal of Clinical Oncology. 

    March 18, 2020
    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says
    Research

    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says

    Overall cancer death rates fell 1.5% on average per year from 2001–2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer from the Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), American Cancer Society, and North American Association of Central Cancer Registries.

    March 16, 2020
    Oncolytic Virus Kills Tumor Cells While Supporting T Cells
    Research

    Oncolytic Virus Kills Tumor Cells While Supporting T Cells

    A new type of dual-function oncolytic virus that simultaneously kills cancer cells while increasing levels of leptin to support T cells is showing promise in melanoma mouse models, researchers reported in Immunity.   

    March 11, 2020
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page
    • Last page Last »
     
    picture of the author
    Elisa Becze BA, ELS, Editor
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2020 Oncology Nursing Society
     
    Back to Top ▲